(Q28219114)

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01720.X

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01720.X

Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01720.X

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01720.X

Use of selective serotonin reuptake inhibitors and the risk of stroke: is there reason for concern?

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.2006.01720.X

Selective serotonin reuptake inhibitors. Pharmacology and clinical implications in anaesthesia and critical care medicine

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Selective serotonin reuptake inhibitors: infrequent medical adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Platelet activation in depression and effects of sertraline treatment: An open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Intracranial haemorrhage and use of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Association between SSRIs and upper gastrointestinal bleeding. Coprescription of antiulcer drugs with SSRIs is fairly common

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X

Antidepressants and upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01720.X